Article Details

Vaccitech, startup behind Oxford COVID-19 vaccine tech, falls 20% in Nasdaq debut

Retrieved on: 2021-04-30 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Vaccitech, startup behind Oxford COVID-19 vaccine tech, falls 20% in Nasdaq debut. View article details on hiswai:

Excerpt

The biotech startup has already raised $216 million to date from Gilead Sciences, Sequoia Capital China and Oxford Sciences Innovation.

Article found on: whbl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo